Back to Search
JEFFREY HAMBLETON, MD
MD
Family Medicine Physician
NPI: 1750482345Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors.
PMID 19415281·Cancer Chemother Pharmacol·2009
3-trial
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial.
PMID 18791166·Blood·2008
4-observational
Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer.
PMID 18024865·J Clin Oncol·2007
3-trial
Viability of red cells prepared with S-303 pathogen inactivation treatment.
PMID 17002635·Transfusion·2006
3-trial
Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies.
PMID 16078927·Transfusion·2005
3-trial
Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer.
PMID 15908660·J Clin Oncol·2005
3-trial
Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer.
PMID 15867200·J Clin Oncol·2005
3-trial
The influence of ethnicity on warfarin dosage requirement.
PMID 15855242·Ann Pharmacother·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 19200 N KELSEY ST
MONROE, WA 98272 - Phone
- (360) 794-7994
Quick Facts
- NPI
- 1750482345
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile